Summary
- Profile Type
- Technology request
- POD Reference
- TRGB20250331014
- Term of Validity
- 31 March 2025 - 31 March 2026
- Company's Country
- United Kingdom
- Type of partnership
- Research and development cooperation agreement
- Commercial agreement with technical assistance
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
-
The UK based SME is revolutionising gut disorder treatment by merging cutting-edge science with advanced AI modelling. Their AI-Discovery platform transforms vast human genetic data into disease signatures and therapy targets. Through their unique and targeted microbiome therapy, they look to restore a healthy gut balance, eliminating symptoms of irritable bowel syndrome and other gut disorders.
The company is seeking access to datasets related to the gut microbiome. - Full Description
-
The London-based biotech company revolutionising gut disorder treatments by combining advanced AI modelling with innovative microbiome therapies .
As a data-driven company, they are actively seeking IBS and IBD datasets to power their AI discovery platform. They welcome collaborations with academic researchers and enterprises that have datasets on irritable bowel syndrome (IBS) and Inflammatory Bowel Disease (IBD).
The company is seeking access to datasets related to the gut microbiome such as anonymised data from patients suffering from gastrointestinal disorders e.g. IBS. Partners could be higher education institutions or business organisations that handle microbiome datasets and are able to share data under a commercial partnership.
Collaborative opportunities include patient studies, co-developing R&D projects, joint research publications, academic secondments, and PhD fellowship programs. - Technical Specification or Expertise Sought
- Access to data, including metagenomic, metabolomic, and patient data related to IBS/IBD or relevant gut disorders.
- Stage of Development
- Under development
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
Partner Sought
- Expected Role of a Partner
- Ideal partners would be able to provide access to available data sought, as well as offer the potential to: partner on patient studies, co-developing R&D projects, publishing joint research, facilitating academic secondments, and exploring establishing PhD fellowship programs.
- Type and Size of Partner
- SME <=10
- SME 11-49
- SME 50 - 249
- Big company
- Other
- University
- R&D Institution
- Type of partnership
- Research and development cooperation agreement
- Commercial agreement with technical assistance
Dissemination
- Technology keywords
- 06003003 - Population genetics
- 06003002 - Gene Expression, Proteome Research
- 06003001 - Bioinformatics
- 06005003 - Health information management
- Market keywords
- 05003001 - Therapeutic services
- 05001005 - Molecular diagnosis
- 05001001 - Diagnostic services
- Targeted countries
- All countries